338 related articles for article (PubMed ID: 4826383)
21. Controlling diabetes with diet and oral hypoglycemic agents.
Faludi G
Geriatrics; 1976 Oct; 31(10):67-70. PubMed ID: 964602
[No Abstract] [Full Text] [Related]
22. [Clinical study of a new oral hypoglycemic agent: glypentide (UR-661)].
Calvet JM; Matarrodona M; Bordas R
Rev Iber Endocrinol; 1974; 21(124):347-62. PubMed ID: 4453782
[No Abstract] [Full Text] [Related]
23. [Clinical evaluation of glidiazinamide].
Pedrazzi F; Bommartini F
G Gerontol; 1972 May; 20(5):459-67. PubMed ID: 4626363
[No Abstract] [Full Text] [Related]
24. [Oral hypoglycemic therapy of diabetes mellitus].
Montenero P
Minerva Med; 1976 Jan; 67(3):208-15. PubMed ID: 1250219
[No Abstract] [Full Text] [Related]
25. An open comparative study of the efficacy and tolerance of a new antidiabetic agent: glipizide.
De Leeuw I; De Baere H; Decraene P; Lemmens P; Verhaegen H
Diabetologia; 1973 Sep; ():364-6. PubMed ID: 4204093
[No Abstract] [Full Text] [Related]
26. [The real problem in diabetes (trial of gliclazide, an original molecule with metabolic and vascular properties)].
Masbernard A; Portal A
Therapeutique; 1972 Nov; 48(9):569-73. PubMed ID: 4650526
[No Abstract] [Full Text] [Related]
27. [Differential therapy using oral antidiabetics].
Mehnert H
Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
[No Abstract] [Full Text] [Related]
28. [Study on Gliclazide, an antidiabetic with a double vascular and metabolic polarity].
Simonin R
Mars Med; 1972; 109(10):655-8. PubMed ID: 4659845
[No Abstract] [Full Text] [Related]
29. [Therapy of diabetes in adults using Glibornurid. Results and clinical studies].
Schöffling K; Mehnert H; Ewald W; Haupt E; Wicklmayr M; Beyer J; Nemeth N
Dtsch Med Wochenschr; 1973 May; 98(18):915-9. PubMed ID: 4633717
[No Abstract] [Full Text] [Related]
30. [Clinical study with glypentide, new sulfonylurea hypoglycemic agent].
Pou Torelló JM; Vilaclara JM
Rev Iber Endocrinol; 1974; 21(125):427-30, 433-8, 441-2 passim. PubMed ID: 4608666
[No Abstract] [Full Text] [Related]
31. [Clinical study of a new sulfonylurea antidiabetic, glibornuride].
Vernet A; Fabre J; Zahnd G
Schweiz Rundsch Med Prax; 1972 Dec; 61(52):1599-607. PubMed ID: 4630563
[No Abstract] [Full Text] [Related]
32. [Clinical trial with glypentide. Comparison with the hypoglycemic activity of other sulfonylurea compounds].
López JM; Khoury G; Fernández RC; COBOS JM; Huelva JL
Rev Iber Endocrinol; 1976; 23(134):181-96. PubMed ID: 778973
[TBL] [Abstract][Full Text] [Related]
33. Improvement in motor nerve conduction following treatment in newly diagnosed diabetics.
Ward JD
Adv Metab Disord; 1973; 2():Suppl 2:569-73. PubMed ID: 4720388
[No Abstract] [Full Text] [Related]
34. [Oral antidiabetics].
Bäbler M
Schweiz Rundsch Med Prax; 1972 Feb; 61(8):242-6. PubMed ID: 4659095
[No Abstract] [Full Text] [Related]
35. [Treatment of diabetes mellitus with glibornurid].
Vignati E; Liuzzi A; Chiodini PG
Minerva Med; 1973 Oct; 64(75):3900-6. PubMed ID: 4767761
[No Abstract] [Full Text] [Related]
36. A new antidiabetic agent.
Gupta SD; Mukerjee AB
J Indian Med Assoc; 1974 Dec; 63(11):357-9. PubMed ID: 4282091
[No Abstract] [Full Text] [Related]
37. [Long term study of a new antidiabetic agent in 1183 cases].
Riveline B
Sem Hop Ther; 1974 Feb; 50(2):133-9. PubMed ID: 4612707
[No Abstract] [Full Text] [Related]
38. Long term treatment of diabetes mellitus with glibornuride. A new hypoglycemic agent.
Nava M; Quibrera R; Pérez Arocha N
Rev Invest Clin; 1973; 25(2):169-74. PubMed ID: 4198609
[No Abstract] [Full Text] [Related]
39. [What is reliable in the therapy of diabetes mellitus?].
Sauer H; Böninger C
Internist (Berl); 1970 Dec; 11(12):430-6. PubMed ID: 4924814
[No Abstract] [Full Text] [Related]
40. Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide.
Artini D; Abbiati R; Orsini G; Parenti MA; Bloch K; Daturi S; Mandelli V
Diabetologia; 1973 Sep; ():311-6. PubMed ID: 4204091
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
